Sayak Banerjee, Amity University Kolkata According to the scientists at Baylor College of Medicine, antiviral immune pathways in triple-negative breast cancers (TNBC) can be activated by therapeutics targeting RNA splicing along with the stimulation of tumour cell death. Around 10-20% of breast cancers are triple-negative, which signifies that they are negative not only for estrogen […]
Parnad Basu, Amity University Kolkata Breast cancer is the second most common cancer in the United States, which happens to women but is also seen in men in some rare cases. Now, triple-negative breast cancer (TNBC) is a specific type of breast cancer where the cancer cells show negative results for estrogen receptor, progesterone receptor, […]
Sagnik Nag, Amity University Kolkata Breast cancer is among the second largest cause of deaths among women related to cancer. The development of breast cancer is a multi-step process that involves numerous cell types and its treatment remains shrouded with many challenges. Triple-negative breast cancers (TNBC) is accounted for 10-15% of all breast cancers. Triple-negative breast […]
